Aier Eye Hospital Group

ISIN CNE100000GR6

 | 

WKN A1J1QA

 

Overview

Description

Aier Eye Hospital Group Co., Ltd. engages in the management and operation of ophthalmic chain medical institutions. It provides patients with ophthalmology medical services such as diagnosis, treatment and medical optometry of ophthalmic diseases. The company's medical treatments include myopia surgery, prevention & treatment of myopia, cataract, glaucoma, pediatric ophthalmology, fundus disease, eye shaping beauty, lacrimal pathology, cornea and ocular surface. Aier Eye Hospital Group was founded by Bang Chen and Li Li on January 24, 2003 and is headquartered in Changsha, China.
Show more Show less
Healthcare Healthcare Services Patient Care China

Financials

Key metrics

Market capitalisation, EUR 14,402.24 m
EPS, EUR 0.05
P/B ratio 5.79
P/E ratio 32.57
Dividend yield 1.17%

Income statement (2023)

Revenue, EUR 2,655.33 m
Net income, EUR 438.95 m
Profit margin 16.53%

What ETF is Aier Eye Hospital Group in?

There are 93 ETFs which contain Aier Eye Hospital Group. All of these ETFs are listed in the table below. The ETF with the largest weighting of Aier Eye Hospital Group is the Invesco ChiNext 50 UCITS ETF Acc.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.